REFERENCES
- Keller J., Bunger C., Andreassen T. T., Bak B., Lucht U. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop. Scand. 1987; 58: 379–383, [PUBMED], [INFOTRIEVE], [CSA]
- Allen H. L., Wase A., Bear W. T. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop. Scand. 1980; 51: 595–600, [PUBMED], [INFOTRIEVE], [CSA]
- Nilsson O. S., Bauer H. C., Brosjo O., Tornkvist H. Influence of indomethacin on induced heterotopic bone formation in rats. Importance of length of treatment and of age. Clin. Orthop. 1986; 207: 239–245, [PUBMED], [INFOTRIEVE], [CSA]
- Tornkvist H., Lindholm T. S. Effect of ibuprofen on mass and composition of fracture callus and bone. An experimental study on adult rat. Scand. J. Rheumatol. 1980; 9: 167–171, [PUBMED], [INFOTRIEVE], [CSA]
- Tornkvist H., Bauer F. C., Nilsson O. S. Influence of indomethacin on experimental bone metabolism in rats. Clin. Orthop. 1985; 193: 264–270, [PUBMED], [INFOTRIEVE], [CSA]
- Ho M. L., Chang J. K., Wang G. J. Antiinflammatory drug effects on bone repair and remodeling in rabbits. Clin. Orthop. 1995; 313: 270–278, [PUBMED], [INFOTRIEVE], [CSA]
- Ho M. L., Chang J. K., Wang G. J. Effects of ketorolac on bone repair: a radiographic study in modeled demineralized bone matrix grafted rabbits. Pharmacology 1998; 57: 148–159, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ho M. L., Chang J. K., Chuang L. Y., Hsu H. K., Wang G. J. Effects of nonsteroidal anti-inflammatory drugs and prostaglandins on osteoblastic functions. Biochem. Pharmacol. 1999; 58: 983–990, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Parfitt A. M. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J. Cell Biochem. 1994; 55: 273–286, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Parfitt A. M. Bone-forming cells in clinical condictions. The Osteoblast and Osteocyte. Telford and CRC Press, Boca Raton, FL 1990; 351–429
- Jilka R. L., Weinstein R. S., Bellido T., Parfitt A. M., Manolagas S. C. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone. Miner. Res. 1998; 13: 793–802, [PUBMED], [INFOTRIEVE], [CSA]
- Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 52: 345–347, [CSA], [CROSSREF]
- Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847–849, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L., Wyllie A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 62: 849–852, [CSA], [CROSSREF]
- Zhang G., Tu C., Zhou G., Zheng W. Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells. Leuk. Res. 2000; 24: 385–392, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 1996; 52: 237–245, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Picariello L., Brandi M. L., Formigli L., Orlandini S. Z., Dolara P., Caderni G., Raimondi L., Tonelli F. Apoptosis induced by sulindac sulfide in epithelial and mesenchymal cells from human abdominal neoplasms. Eur. J. Pharmacol. 1998; 360: 105–112, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rahman M. A., Dhar D. K., Masunaga R., Yamanoi A., Kohno H., Nagasue N. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res. 2000; 60: 2085–2089, [PUBMED], [INFOTRIEVE], [CSA]
- Piazza G. A., Rahm A. K., Finn T. S., Fryer B. H., Li H., Stoumen A. L., Pamukcu R., Ahnen D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res. 1997; 57: 2452–2459, [PUBMED], [INFOTRIEVE], [CSA]
- Arber N., Han E. K., Sgambato A., Piazza G. A., Delohery T. M., Begemann M., Weghorst C. M., Kim N. H., Pamukcu R., Ahnen D. J., Reed J. C., Weinstein I. B., Holt P. R. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes. Gastroenterology 1997; 113: 1892–1900, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shiff S. J., Koutsos M. I., Qiao L., Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res. 1996; 222: 179–188, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Goldberg Y., Nassif I I, Pittas A., Tsai L. L., Dynlacht B. D., Rigas B., Shiff S. J. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. Oncogene 1996; 12: 893–901, [PUBMED], [INFOTRIEVE], [CSA]
- Ueno K., Haba T., Woodbury D., Price P., Anderson R., Jee W. S. The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. Bone 1985; 6: 79–86, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Furuta Y., Jee W. S. Effect of 16,16-dimethyl prostaglandin E2 methyl ester on weanling rat skeleton: daily and systemic administration. Anat. Rec. 1986; 215: 305–316, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shih M. S., Norrdin R. W. Effect of prostaglandin E2 on rib fracture healing in beagles: histomorphometric study on periosteum adjacent to the fracture site. Am. J. Vet. Res. 1986; 47: 1561–1564, [PUBMED], [INFOTRIEVE], [CSA]
- Shih M. S., Norrdin R. W. PGE2 induces regional remodeling changes in haversian envelope: a histomorphometric study of fractured ribs in beagles. Bone Miner. 1986; 1: 227–234, [PUBMED], [INFOTRIEVE], [CSA]
- Shih M. S., Norrdin R. W. Effect of PGE2 on regional cortico-endosteal remodeling in beagles with fractured ribs: a histomorphometric study. Bone Miner. 1987; 3: 27–34, [PUBMED], [INFOTRIEVE], [CSA]
- Jee W. S., Ueno K., Deng Y. P., Woodbury D. M. The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif. Tissue Int. 1985; 37: 148–157, [PUBMED], [INFOTRIEVE], [CSA]
- Mori S., Jee W. S., Li X. J., Chan S., Kimmel D. B. Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats. Bone 1990; 11: 103–113, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kawaguchi H., Pilbeam C. C., Harrison J. R., Raisz L. G. The role of prostaglandins in the regulation of bone metabolism. Clin. Orthop. 1995; 313: 36–46, [PUBMED], [INFOTRIEVE], [CSA]
- Klaushofer K., Hoffmann O., Czerwenka E., Leis H. J., Gleispach H., Koller K., Peterlik M. Comparison of the inhibitory effect of nonsteroidal antiinflammatory drugs on bone prostaglandin synthesis and resorption. J. Rheumatol. 1988; 15: 486–491, [PUBMED], [INFOTRIEVE], [CSA]
- Norrdin R. W., Jee W. S., High W. B. The role of prostaglandins in bone in vivo. Prostag. Leukot. Essent. Fatty Acids 1990; 41: 139–149, [CSA], [CROSSREF]
- Centrella M., McCarthy T. L., Canalis E. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J. Biol. Chem. 1987; 262: 2869–2874, [PUBMED], [INFOTRIEVE], [CSA]
- Wong G. L., Cohn D. V. Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc. Natl. Acad. Sci. USA 1975; 72: 3167–3171, [PUBMED], [INFOTRIEVE], [CSA]
- Centrella M., Casinghino S., McCarthy T. L. Differential actions of prostaglandins in separate cell populations from fetal rat bone. Endocrinology 1994; 135: 1611–1620, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hagiwara H., Inoue A., Nakajo S., Nakaya K., Kojima S., Hirose S. Inhibition of proliferation of chondrocytes by specific receptors in response to retinoids. Biochem. Biophys. Res. Commun. 1996; 222: 220–224, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morrison C., Macnair R., MacDonald C., Wykman A., Goldie I., Grant M. H. In vitro biocompatibility testing of polymers for orthopaedic implants using cultured fibroblasts and osteoblasts. Biomaterials 1995; 16: 987–992, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ikezawa K., Ohtsubo M., Norwood T. H., Narayanan A. S. Role of cyclin E and cyclin E-dependent kinase in mitogenic stimulation by cementum-derived growth factor in human fibroblasts. FASEB J. 1998; 12: 1233–1239, [PUBMED], [INFOTRIEVE], [CSA]
- Suzuki N., Hattori A. Bisphenol A suppresses osteoclastic and osteoblastic activities in the cultured scales of goldfish. Life Sci. 2003; 73: 2237–2247, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hsu C., Hsieh Y. L., Ho M. L., Hsu H. K., Yu J. Y. Sexually dimorphic effect of glutamate treatment on cell cycle arrestment of astrocytes from the preoptic area of neonatal rats. Dev. Neurosci. 2001; 23: 399–405, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 1975; 66: 188–193, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Crowston J. G., Akbar A. N., Constable P. H., Occleston N. L., Daniels J. T., Khaw P. T. Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest. Ophthalmol Vis. Sci. 1998; 39: 449–454, [PUBMED], [INFOTRIEVE], [CSA]
- Mesner P. W., Jr., Kaufmann S. H. Methods utilized in the study of apoptosis. Adv. Pharmacol. 1997; 41: 57–87, [PUBMED], [INFOTRIEVE], [CSA]
- Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992; 119: 493–501, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hsu H. K., Yang R. C., Shih H. C., Hsieh Y. L., Chen U. Y., Hsu C. Prenatal exposure of testosterone prevents SDN-POA neurons of postnatal male rats from apoptosis through NMDA receptor. J. Neurophysiol. 2001; 86: 2374–2380, [PUBMED], [INFOTRIEVE], [CSA]
- Ornberg R. L. Proliferation and apoptosis measurements by color image analysis based on differential absorption. J. Histochem. Cytochem. 2001; 49: 1059–1060, [PUBMED], [INFOTRIEVE], [CSA]
- Oberbauer R., Krivanek P., Turnheim K. Pharmacokinetics of indomethacin in the elderly. Clin. Pharmacokinet. 1993; 24: 428–434, [PUBMED], [INFOTRIEVE], [CSA]
- Todd P. A., Sorkin E. M. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1988; 35: 244–285, [PUBMED], [INFOTRIEVE], [CSA]
- Blocka K. L., Richardson C. J., Wallace S. M., Ross S. G., Verbeeck R. K. The effect of age on piroxicam disposition in rheumatoid arthritis. J. Rheumatol. 1988; 15: 757–763, [PUBMED], [INFOTRIEVE], [CSA]
- Buckley M. M., Brogden R. N. Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1990; 39: 86–109, [PUBMED], [INFOTRIEVE], [CSA]
- Hakeda Y., Yoshino T., Natakani Y., Kurihara N., Maeda N., M. K. Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J. Cell Physiol. 1986; 128: 155–161, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Machwate M., Harada S., Leu C. T., Seedor G., Labelle M., Gallant M., Hutchins S., Lachance N., Sawyer N., Slipetz D., Metters K. M., Rodan S. B., Young R., Rodan G. A. Prostaglandin receptor EP4 mediates the bone anabolic effects of PGE2. Mol. Pharmaco. 2001; 60: 36–41, [CSA]
- Yamaguchi D. T., Green J., Merritt B. S., Kleeman C. R., Muallem S. Modulation of osteoblast function by prostaglandins. Am. J. Physiol. 1989; 257: F755–761, [PUBMED], [INFOTRIEVE], [CSA]